Skip to Main Content

Paper Details

Comparative cardiovascular effectiveness of glucagon-like peptide-1 receptor agonists versus sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes: A population-based cohort study.
Diabetes Obes Metab
9
2022
Author NameAffiliation
Sengwee TohHarvard Medical School and Harvard Pilgrim Health Care Institute
  • 1 - 1

Datasets

Release 1.2